222 related articles for article (PubMed ID: 21878627)
1. The minimal active structure of human relaxin-2.
Hossain MA; Rosengren KJ; Samuel CS; Shabanpoor F; Chan LJ; Bathgate RA; Wade JD
J Biol Chem; 2011 Oct; 286(43):37555-65. PubMed ID: 21878627
[TBL] [Abstract][Full Text] [Related]
2. Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin.
Chan LJ; Rosengren KJ; Layfield SL; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
J Biol Chem; 2012 Nov; 287(49):41152-64. PubMed ID: 23024363
[TBL] [Abstract][Full Text] [Related]
3. The roles of the A- and B-chains of human relaxin-2 and -3 on their biological activity.
Hossain MA; Wade JD
Curr Protein Pept Sci; 2010 Dec; 11(8):719-24. PubMed ID: 21235507
[TBL] [Abstract][Full Text] [Related]
4. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
Hossain MA; Wade JD; Bathgate RA
Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
[TBL] [Abstract][Full Text] [Related]
5. Chemically synthesized dicarba H2 relaxin analogues retain strong RXFP1 receptor activity but show an unexpected loss of in vitro serum stability.
Hossain MA; Haugaard-Kedström LM; Rosengren KJ; Bathgate RA; Wade JD
Org Biomol Chem; 2015 Nov; 13(44):10895-903. PubMed ID: 26368576
[TBL] [Abstract][Full Text] [Related]
6. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
Scott DJ; Rosengren KJ; Bathgate RA
Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
[TBL] [Abstract][Full Text] [Related]
7. Synthetic covalently linked dimeric form of H2 relaxin retains native RXFP1 activity and has improved in vitro serum stability.
Nair VB; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
Biomed Res Int; 2015; 2015():731852. PubMed ID: 25685807
[TBL] [Abstract][Full Text] [Related]
8. Solution structure, aggregation behavior, and flexibility of human relaxin-2.
Haugaard-Kedström LM; Hossain MA; Daly NL; Bathgate RA; Rinderknecht E; Wade JD; Craik DJ; Rosengren KJ
ACS Chem Biol; 2015 Mar; 10(3):891-900. PubMed ID: 25547165
[TBL] [Abstract][Full Text] [Related]
9. De novo design and synthesis of cyclic and linear peptides to mimic the binding cassette of human relaxin.
Hossain MA; Bathgate RA; Tregear G; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():16-9. PubMed ID: 19416152
[TBL] [Abstract][Full Text] [Related]
10. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors.
Hossain MA; Rosengren KJ; Haugaard-Jönsson LM; Zhang S; Layfield S; Ferraro T; Daly NL; Tregear GW; Wade JD; Bathgate RA
J Biol Chem; 2008 Jun; 283(25):17287-97. PubMed ID: 18434306
[TBL] [Abstract][Full Text] [Related]
11. Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2.
Sethi A; Bruell S; Ryan T; Yan F; Tanipour MH; Mok YF; Draper-Joyce C; Khandokar Y; Metcalfe RD; Griffin MDW; Scott DJ; Hossain MA; Petrie EJ; Bathgate RAD; Gooley PR
J Mol Biol; 2021 Oct; 433(21):167217. PubMed ID: 34454945
[TBL] [Abstract][Full Text] [Related]
12. Single chain peptide agonists of relaxin receptors.
Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
[TBL] [Abstract][Full Text] [Related]
13. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
14. Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone.
Shabanpoor F; Bathgate RA; Belgi A; Chan LJ; Nair VB; Wade JD; Hossain MA
Biochem Biophys Res Commun; 2012 Apr; 420(2):253-6. PubMed ID: 22425984
[TBL] [Abstract][Full Text] [Related]
15. Modeling the primary hormone-binding site of RXFP1 and RXFP2.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162
[TBL] [Abstract][Full Text] [Related]
16. The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1.
Sethi A; Bruell S; Patil N; Hossain MA; Scott DJ; Petrie EJ; Bathgate RAD; Gooley PR
Nat Commun; 2016 Apr; 7():11344. PubMed ID: 27088579
[TBL] [Abstract][Full Text] [Related]
17. Structure and activity in the relaxin family of peptides.
Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
[TBL] [Abstract][Full Text] [Related]
18. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
19. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
[TBL] [Abstract][Full Text] [Related]
20. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
